SEALSQ Corp (LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced its ...

SEALSQ Corp (NASDAQ: LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Vivek Yadav, an engineering manager from ...

Boston University undergraduate students can now earn a certificate in generative artificial intelligence by completing a free, online course available through the BU portal. The course, “AI at BU,” ...

Collaboration leverages Ventus’ physics-based and AI/ML-enabled ReSOLVE ® platform to initiate discovery programs for multiple therapeutic targets and support medicinal chemistry strategy for active ...

GARDEN CITY, Long Island (WABC) -- A college student on Long Island says he was wrongly accused of using artificial intelligence to write an essay, and now he's suing his university. Adelphi ...

STATE COLLEGE, PA. — A joint venture between Georgia-based developer Landmark Properties and Liberty Mutual Investments will develop The Mark State College, a 515-bed student housing project for ...

Mizzou Athletics has teamed up with Edward Jones to offer a new financial resource to benefit its student-athletes. On Wednesday, MU announced that it is launching a financial education program for ...

Nvidia (NASDAQ:NVDA) and Intel (NASDAQ:INTC) announced a blockbuster deal on Thursday to co-develop PC and data center chips. Simultaneously, Nvidia said it would take a $5B stake in Intel. Nvidia ...

Mark Humble believes playing on the road is more than just a challenge — it is a mentality. Harker Heights opened its season last week at Cedar Park, where it rebounded from a slow start to earn a ...

Charm Therapeutics Ltd. is heading to the clinic after closing an oversubscribed series B, which will fund initial development of a menin inhibitor that is AI-designed to circumvent shortcomings of ...